Your session is about to expire
← Back to Search
Play Serious Games with a Social Robot (Ryan) for Alzheimer's Disease
N/A
Waitlist Available
Research Sponsored by DreamFace Technologies, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 months, and 1 year
Awards & highlights
Study Summary
This trial will study the effects of social interaction on cognitive decline in seniors with Alzheimer's.
Eligible Conditions
- Alzheimer's Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 6 months, and 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 months, and 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
change in cognitive/memory ability
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Active GroupExperimental Treatment1 Intervention
Active Group: Group 1 users will play games with and administered by Ryan, 2-3 times a week and 30-minutes per day.
Group II: Control GroupActive Control1 Intervention
Control Group: Group 2 users will play solitary games (word puzzles) and activities but will have no interaction with Ryan.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Play Serious Games with a Social Robot (Ryan)
2020
N/A
~30
Find a Location
Who is running the clinical trial?
DreamFace Technologies, LLCLead Sponsor
2 Previous Clinical Trials
24 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,672 Previous Clinical Trials
28,018,641 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger